United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Pfizer receives FDA approval for Nivestym, a Neutropenia biosimilar Pfizer Inc. has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for… bypharmanewsdailyJuly 21, 2018
